ACP CME 165 2025: focused medical education review
The ACP CME 165 2025 is a video course. The package documents 165 hours, 176 videos, and 27.5 GB. Coverage includes medical education, hypertension, mechanical ventilation, and artificial intelligence in medicine.
-
165hours
-
176videos
-
27.5GB
Inside this resource
Clinical management
This acp cme 165 2025 brings together medical education, cardiovascular care in women, and heart failure. The sequence supports a connected review of the resource’s documented medical education scope.
Clinical management
Coverage then moves through hypertension, atherosclerosis, and heart failure with preserved ejection fraction. These subjects add clinical and technical context without extending beyond the source syllabus.
Clinical management
The course also addresses mechanical ventilation, atrial fibrillation, and ischemic heart disease. Together, these areas round out the stated content for focused cardiology study.
Clinical management
Coverage then moves through artificial intelligence in medicine, cardiometabolic disease, and peripheral arterial testing. These subjects add clinical and technical context without extending beyond the source syllabus.
Who this serves
- Primary care and internal medicine clinicians — Use the resource to review its stated medical education content in one organized package.
- Self-paced learners — Work through the video course according to an individual study schedule.
Before you buy
What files and materials are included?
The package is supplied as video course and documents 165 hours, 176 videos, and 27.5 GB.
Is this resource aligned with my study needs?
The acp cme 165 2025 is intended for primary care and internal medicine clinicians reviewing medical education in a self-paced format.
The chart
| Format | Video Course |
|---|---|
| Duration | 165 hours |
| Year | 2025 |
| Department | Cardiology |
| Delivery | Instant download after checkout · lifetime re-access |
Verified original fileInstant downloadEncrypted checkout



Reviews
There are no reviews yet.